MakeMyTrip stocks are in focus after Morpheus Research alleged anti-competitive practices, potential CCI non-compliance, and accounting concerns, flagging pricing mechanisms, earnings management, and risks linked to its ongoing regulatory appeal.
MakeMyTrip stocks are in focus after Morpheus Research alleged anti-competitive practices, potential CCI non-compliance, and accounting concerns, flagging pricing mechanisms, earnings management, and risks linked to its ongoing regulatory appeal.